Both in Pharmaceuticals
Organon & vs Disc Medicine
Over the past year OGN returned +106.4% and IRON returned −2.4%; their daily moves had a correlation of -0.01.
OGN +106.4% IRON −2.4%Growth of $1, one year, split-adjusted
| Metric | OGN | IRON |
|---|---|---|
| Price | $13.85 | $82.66 |
| Market cap | $3.64B | $3.67B |
| Today | 0.00% | +1.84% |
| 1 month | +0.8% | +34.1% |
| 6 months | +3.3% | +20.4% |
| Year to date | +93.2% | +4.1% |
| 1 year | +106.4% | −2.4% |
| Revenue growth (YoY) | −1.7% | — |
| Gross margin | 55.2% | — |
| Net margin | 10.4% | — |
| P/E (TTM) | 17.1× | — |
| Price / sales | 0.6× | — |
| Net cash | -$7.10B | $658.4M |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.9% | 75.8% |
| Short % of float | 7.2% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).